Variant report
Variant | nsv573027 |
---|---|
Chromosome Location | chr16:76443174-76451242 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1506833 | chr16:76443174-76443175 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs115792628 | chr16:76443185-76443186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566904427 | chr16:76443208-76443209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34516314 | chr16:76443238-76443239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79500103 | chr16:76443267-76443268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs62051219 | chr16:76443298-76443299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs182157801 | chr16:76443328-76443329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537603829 | chr16:76443353-76443354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554654477 | chr16:76443361-76443362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367648578 | chr16:76443385-76443386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138047473 | chr16:76443391-76443392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553840191 | chr16:76443426-76443427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114531473 | chr16:76443427-76443428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546531996 | chr16:76443461-76443462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111613318 | chr16:76443464-76443465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556537109 | chr16:76443473-76443474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569666418 | chr16:76443483-76443484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535382809 | chr16:76443493-76443494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562297317 | chr16:76443516-76443517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568796801 | chr16:76443534-76443535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34449971 | chr16:76443550-76443551 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs565736459 | chr16:76443616-76443617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541104138 | chr16:76443619-76443620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140973943 | chr16:76443629-76443630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568083161 | chr16:76443638-76443639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187167406 | chr16:76443667-76443668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74430927 | chr16:76443673-76443674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369787060 | chr16:76443699-76443700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531632709 | chr16:76443718-76443719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs62051220 | chr16:76443737-76443738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs568232173 | chr16:76443744-76443745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533905540 | chr16:76443767-76443768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145060747 | chr16:76443774-76443775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192096408 | chr16:76443790-76443791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539391567 | chr16:76443797-76443798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556120076 | chr16:76443800-76443801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576957053 | chr16:76443826-76443827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369714972 | chr16:76443837-76443838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372469344 | chr16:76443841-76443842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576704148 | chr16:76443842-76443843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542492490 | chr16:76443850-76443851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555710930 | chr16:76443865-76443866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572277890 | chr16:76443882-76443883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183921442 | chr16:76443916-76443917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564200412 | chr16:76443936-76443937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533159515 | chr16:76443939-76443940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138842277 | chr16:76443955-76443956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563693644 | chr16:76443962-76443963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375416371 | chr16:76443971-76443972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531534365 | chr16:76444002-76444003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 24585490 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76442600-76444600 | Enhancers | Fetal Lung | lung |